Publications by authors named "Dayenne G van Leeuwen"

Claim this Profile
C
Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity.
Royce Ma, Mae Woods, Phillip Burkhardt, Noah Crooks, Dayenne G van Leeuwen

Cell Rep Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies.
Norihiro Watanabe, Feiyan Mo, Rong Zheng, Royce Ma, Vanesa C Bray, Dayenne G van Leeuwen

Mol Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL.
Mark B Geyer, Isabelle Rivière, Brigitte Sénéchal, Xiuyan Wang, Yongzeng Wang, Dayenne G van Leeuwen

JCI Insight· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response.
Nicholas F Kuhn, Terence J Purdon, Dayenne G van Leeuwen, Andrea V Lopez, Kevin J Curran

Cancer Cell· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo.
Sarwish Rafiq, Oladapo O Yeku, Hollie J Jackson, Terence J Purdon, Dayenne G van Leeuwen

Nat Biotechnol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System.
Mauro P Avanzi, Oladapo Yeku, Xinghuo Li, Dinali P Wijewarnasuriya, Dayenne G van Leeuwen

Cell Rep· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression.
Kevin J Curran, Beatrijs A Seinstra, Yan Nikhamin, Raymond Yeh, Yelena Usachenko, Dayenne G van Leeuwen

Mol Ther· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis